Altimmune Inc (NAS:ALT)
$ 7.33 -0.06 (-0.81%) Market Cap: 519.71 Mil Enterprise Value: 342.50 Mil PE Ratio: 0 PB Ratio: 3.00 GF Score: 30/100

Altimmune Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 05:35PM GMT
Release Date Price: $2.67 (+2.30%)
Unidentified Analyst

Hi, everyone, and thank you for joining us today at the fireside chat for Altimmune. I'm very pleased to welcome the President and CEO of Altimmune, Vipin Garg, along with the Chief Medical Officer of the company, Scott Harris. And before we get into questions, I'm just going to read a quick research disclosure.

So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. So just for those in the audience, maybe not as familiar with the Altimmune story, maybe Vipin, you can start.

Questions & Answers

Unidentified Analyst

Just give a brief introduction of yourselves and what you're focused on in the near term.

Vipin K. Garg
Altimmune, Inc. - President, CEO & Director

Absolutely. Well, thank you for having us, Kelly, looking forward to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot